Passive immunotherapy for Middle East Respiratory Syndrome coronavirus infection with equine immunoglobulin or immunoglobulin fragments in a mouse model

Antiviral Research

Volumn 137, Issue , 2017, Pages 125-130

  Zhao, Yongkun ^a,f   Wang, Chong ^a,b   Qiu, Boning ^a,c   Li, Chufang ^e   Wang, Hualei ^a,f   Jin, Hongli ^a   Gai, Weiwei ^a,c   Zheng, Xuexing ^a   Wang, Tiecheng ^a,f   Sun, Weiyang ^a,f   Yan, Feihu ^a   Gao, Yuwei ^a,f   Wang, Qian ^e   Yan, Jinghua ^g   Chen, Ling ^e   Perlman, Stanley ^d   Zhong, Nanshan ^e   Zhao, Jincun ^e   Yang, Songtao ^a,f   Xia, Xianzhu ^a,f  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c JILIN UNIVERSITY   (China)

^d UNIVERSITY OF IOWA   (United States)

^e GUANGZHOU MEDICAL UNIVERSITY   (China)

^f YANGZHOU UNIVERSITY   (China)

^g INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

Animal model; Equine immune serum; F(ab )2 fragment; Immunoglobulin; Middle East Respiratory Syndrome coronavirus

Indexed keywords

E PROTEIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; M PROTEIN; NEUTRALIZING ANTIBODY; PEPSIN A; UNCLASSIFIED DRUG; VIRAL PROTEIN; VITRONECTIN; F(AB')2 RECEPTOR; IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN RECEPTOR; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; FEMALE; HORSE; IMMUNOTHERAPY; LUNG; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRAL CLEARANCE; VIRUS LIKE AGENT; VIRUS LOAD; ANIMAL; CORONAVIRUS INFECTION; DISEASE MODEL; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; PASSIVE IMMUNIZATION; RESPIRATORY TRACT INFECTION; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CORONAVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; HORSES; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN G; MICE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; RECEPTORS, IMMUNOLOGIC; RESPIRATORY TRACT INFECTIONS;

EID: 85002187619     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2016.11.016     Document Type: Article

References (25)

1. Assiri, A., Al-Tawfiq, J.A., Al-Rabeeah, A.A., Al-Rabiah, F.A., Al-Hajjar, S., Al-Barrak, A., Flemban, H., Al-Nassir, W.N., Balkhy, H.H., Al-Hakeem, R.F., Makhdoom, H.Q., Zumla, A.I., Memish, Z.A., Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis. 13 (2013), 752–761.
2. Assiri, A., McGeer, A., Perl, T.M., Price, C.S., Al Rabeeah, A.A., Cummings, D.A., Alabdullatif, Z.N., Assad, M., Almulhim, A., Makhdoom, H., Madani, H., Alhakeem, R., Al-Tawfiq, J.A., Cotten, M., Watson, S.J., Kellam, P., Zumla, A.I., Memish, Z.A., Team, K.M.-C.I., Hospital outbreak of Middle East respiratory syndrome coronavirus. N. Engl. J. Med. 369 (2013), 407–416.
3. Both, L., Banyard, A.C., van Dolleweerd, C., Horton, D.L., Ma, J.K., Fooks, A.R., Passive immunity in the prevention of rabies. Lancet Infect. Dis. 12 (2012), 397–407.
4. Corti, D., Zhao, J., Pedotti, M., Simonelli, L., Agnihothram, S., Fett, C., Fernandez-Rodriguez, B., Foglierini, M., Agatic, G., Vanzetta, F., Gopal, R., Langrish, C.J., Barrett, N.A., Sallusto, F., Baric, R.S., Varani, L., Zambon, M., Perlman, S., Lanzavecchia, A., Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 10473–10478.
5. Drosten, C., Meyer, B., Muller, M.A., Corman, V.M., Al-Masri, M., Hossain, R., Madani, H., Sieberg, A., Bosch, B.J., Lattwein, E., Alhakeem, R.F., Assiri, A.M., Hajomar, W., Albarrak, A.M., Al-Tawfiq, J.A., Zumla, A.I., Memish, Z.A., Transmission of MERS-coronavirus in household contacts. N. Engl. J. Med. 371 (2014), 828–835.
6. Drosten, C., Seilmaier, M., Corman, V.M., Hartmann, W., Scheible, G., Sack, S., Guggemos, W., Kallies, R., Muth, D., Junglen, S., Muller, M.A., Haas, W., Guberina, H., Rohnisch, T., Schmid-Wendtner, M., Aldabbagh, S., Dittmer, U., Gold, H., Graf, P., Bonin, F., Rambaut, A., Wendtner, C.M., Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect. Dis. 13 (2013), 745–751.
7. Du, L., Zhao, G., Kou, Z., Ma, C., Sun, S., Poon, V.K., Lu, L., Wang, L., Debnath, A.K., Zheng, B.J., Zhou, Y., Jiang, S., Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development. J. Virology 87 (2013), 9939–9942.
8. Gutierrez, J.M., Lomonte, B., Sanz, L., Calvete, J.J., Pla, D., Immunological profile of antivenoms: preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays. J. Proteomics 105 (2014), 340–350.
9. Hayden, F.G., Farrar, J., Peiris, J.S.M., Towards improving clinical management of Middle East respiratory syndrome coronavirus infection. Lancet Infect. Dis. 14 (2014), 544–546.
10. He, Y., Zhu, Q., Liu, S., Zhou, Y., Yang, B., Li, J., Jiang, S., Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines. Virology 334 (2005), 74–82.
11. Li, Y., Wan, Y., Liu, P., Zhao, J., Lu, G., Qi, J., Wang, Q., Lu, X., Wu, Y., Liu, W., Zhang, B., Yuen, K.Y., Perlman, S., Gao, G.F., Yan, J., A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein. Cell Res. 25 (2015), 1237–1249.
12. Lu, J., Guo, Z., Pan, X., Wang, G., Zhang, D., Li, Y., Tan, B., Ouyang, L., Yu, X., Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice. Respir. Res., 7, 2006, 43.
13. Luke, T., Wu, H., Zhao, J., Channappanavar, R., Coleman, C.M., Jiao, J.A., Matsushita, H., Liu, Y., Postnikova, E.N., Ork, B.L., Glenn, G., Flyer, D., Defang, G., Raviprakash, K., Kochel, T., Wang, J., Nie, W., Smith, G., Hensley, L.E., Olinger, G.G., Kuhn, J.H., Holbrook, M.R., Johnson, R.F., Perlman, S., Sullivan, E., Frieman, M.B., Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo. Sci. Transl. Med., 8, 2016, 326ra321.
14. Mair-Jenkins, J., Saavedra-Campos, M., Baillie, J.K., Cleary, P., Khaw, F.M., Lim, W.S., Makki, S., Rooney, K.D., Beck, C.R., The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J. Infect. Dis. 211 (2015), 80–90.
15. Mou, H., Raj, V.S., van Kuppeveld, F.J., Rottier, P.J., Haagmans, B.L., Bosch, B.J., The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. J. Virology 87 (2013), 9379–9383.
16. Peiris, J.S., Guan, Y., Yuen, K.Y., Severe acute respiratory syndrome. Nat. Med. 10 (2004), S88–S97.
17. Sabir, J.S., Lam, T.T., Ahmed, M.M., Li, L., Shen, Y., Abo-Aba, S.E., Qureshi, M.I., Abu-Zeid, M., Zhang, Y., Khiyami, M.A., Alharbi, N.S., Hajrah, N.H., Sabir, M.J., Mutwakil, M.H., Kabli, S.A., Alsulaimany, F.A., Obaid, A.Y., Zhou, B., Smith, D.K., Holmes, E.C., Zhu, H., Guan, Y., Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia. Science 351 (2016), 81–84.
18. Wang, C.Z.X., Gai, W., Zhao, Y., Wang, H., Wang, H., Feng, N., Chi, H., Qiu, B., Li, N., Wang, T., Gao, Y., Yang, S., Xia, X., MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques. Oncotarget, 2016 (in press).
19. Zaki, A.M., van Boheemen, S., Bestebroer, T.M., Osterhaus, A.D., Fouchier, R.A., Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367 (2012), 1814–1820.
20. Zaki, A.M., van Boheemen, S., Bestebroer, T.M., Osterhaus, A.D.M.E., Fouchier, R.A.M., Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367 (2012), 1814–1820.
21. Zhao, J., Li, K., Wohlford-Lenane, C., Agnihothram, S.S., Fett, C., Gale, M.J. Jr., Baric, R.S., Enjuanes, L., Gallagher, T., McCray, P.B. Jr., Perlman, S., Rapid generation of a mouse model for Middle East respiratory syndrome. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 4970–4975.
22. Zhao, J., Perera, R.A., Kayali, G., Meyerholz, D., Perlman, S., Peiris, M., Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection. J. virology 89 (2015), 6117–6120.
23. Zheng, X., Wong, G., Zhao, Y., Wang, H., He, S., Bi, Y., Chen, W., Jin, H., Gai, W., Chu, D., Cao, Z., Wang, C., Fan, Q., Chi, H., Gao, Y., Wang, T., Feng, N., Yan, F., Huang, G., Zheng, Y., Li, N., Li, Y., Qian, J., Zou, Y., Kobinger, G., Gao, G.F., Qiu, X., Yang, S., Xia, X., Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection. Sci. Rep., 6, 2016, 24179.
24. Zhou, L., Ni, B., Luo, D., Zhao, G., Jia, Z., Zhang, L., Lin, Z., Wang, L., Zhang, S., Xing, L., Li, J., Liang, Y., Shi, X., Zhao, T., Zhou, L., Wu, Y., Wang, X., Inhibition of infection caused by severe acute respiratory syndrome-associated coronavirus by equine neutralizing antibody in aged mice. Int. Immunopharmacol. 7 (2007), 392–400.
25. Zumla, A., Hui, D.S., Perlman, S., Middle East respiratory syndrome. Lancet 386 (2015), 995–1007.